Skip to search formSkip to main contentSkip to account menu

Binet Stage A

Patients have no anemia or thrombocytopenia and fewer than three areas of lymphoid involvement.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Disease-specific complications of chronic lymphocytic leukemia in binet stage a patients
Disease-specific Complications of Chronic Lymphocytic Leukemia in Binet Stage A Patients: Analysis of Immunodeficiency… 
2011
2011
LPL is the strongest prognostic factor in a comparative analysis of RNA-based markers in early chronic lymphocytic leukemia
Background The expression levels of LPL, ZAP70, TCL1A, CLLU1 and MCL1 have recently been proposed as prognostic factors in… 
2010
2010
Prognostic relevance of in vitro response to cell stimulation via surface IgD in binet stage a CLL
struggled with peripheral venous access and recurrent portocath thromboses followed by failure of a surgically created… 
2010
2010
Incidence of Cytogenetic Abnormalities In Newly Diagnosed Binet Stage A CLL and Relationship with Prognostic Biomarkers and with Stereotyped B Cell Receptors: Updated Results on 344 Patients Included…
Abstract 4613 Background: Biologic risk factors such as immunoglobulin variable heavy chain (IgV H ) gene mutation status and… 
2009
2009
Early and risk adapted therapy with Fludarabine in high risk binet stage a chronic lymphocytic leukemia patients
Background Fludarabine, a nucleoside analogue, has established itself as a very potent and effective substance for treating CLL… 
2009
2009
Incidence of Cytogenetic Abnormalities in Newly Diagnosed Binet Stage A B-CLL and Relationship with Prognostic Biomarkers: Preliminary Results On 305 Patients Included in the Prospective O-CLL1 GISL…
Abstract 2341 Poster Board II-318 Background. The clinical heterogeneity of chronic lymphocytic leukemia (CLL) requires… 
Highly Cited
2009
Highly Cited
2009
Definition of progression risk based on combinations of cellular and molecular markers in patients with Binet stage A chronic lymphocytic leukaemia
IGHV mutational status and ZAP‐70 or CD38 expression correlate with clinical course in B‐cell chronic lymphocytic leukaemia (CLL… 
2007
2007
Early and Risk-Adapted Therapy with Fludarabine in High-Risk Binet Stage A CLL Patients Prolongs Progression Free Survival but Not Overall Survival: Results of the CLL1 Protocol of the German CLL…
Background: Most patients (pts) with CLL present at early stages of their disease. This group is not homogenous with regard to… 
Review
2005
Review
2005
Cytogenetic Abnormalities in B-CLL at Binet Stage A: Overview in a Cohort of 484 Untreated Patients and Relations with the ZAP-70 and IgVH Mutation Status.
Since January 2004, the French Ministry of Health supports a multicentric study aimed at detecting biological prognostic markers… 
2004
2004
Bcl-6 mutation status provides clinically valuable information in early-stage B-cell chronic lymphocytic leukemia
In B-cell chronic lymphocytic leukemia (B-CLL), somatic mutation of IgVH genes defines a subgroup with favorable prognosis… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)